{"id":3413,"date":"1998-01-01T00:00:00","date_gmt":"1998-01-01T05:00:00","guid":{"rendered":"https:\/\/icesontario.wpengine.com\/journal-articles\/a-research-program-to-evaluate-the-benefits-of-low-dose-cardiovascular-medications-optimizing-prescribing-for-older-women\/"},"modified":"2023-06-14T19:37:56","modified_gmt":"2023-06-14T23:37:56","slug":"a-research-program-to-evaluate-the-benefits-of-low-dose-cardiovascular-medications-optimizing-prescribing-for-older-women","status":"publish","type":"journal_article","link":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/a-research-program-to-evaluate-the-benefits-of-low-dose-cardiovascular-medications-optimizing-prescribing-for-older-women\/","title":{"rendered":"A research program to evaluate the benefits of low dose cardiovascular medications: optimizing prescribing for older women"},"content":{"rendered":"<p>Developing strategies to optimize prescribing for seniors is important because prescription drug expenditures for this group are increasing at a faster rate than any other Canadian healthcare cost. While seniors represent only 12% of the they receive up to 40% of all medications prescribed, amounting to an average of five medications daily. In addition, older people are vulnerable to adverse drug effects which can be dangerous and costly. Medication problems account for up to 28% of hospital admissions for patients over 50,4 up to 70% of which are due to adverse drug reaction. In the U.S., the annual cost of drug-related morbidity and mortality in the ambulatory setting is estimated at 76.6 billion dollars. Therefore, drug-related morbidity and mortality represents a serious though largely preventable medical problem.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Developing strategies to optimize prescribing for seniors is important because prescription drug expenditures for this group are increasing at a faster rate than any other Canadian healthcare cost. While seniors represent only 12% of the they receive up to 40% of all medications prescribed, amounting to an average of five medications daily. In addition, older [&hellip;]<\/p>\n","protected":false},"template":"","migration-helper-automated":[],"migration-manual":[],"topic":[56],"migration-helper-qa-sample-set":[],"class_list":["post-3413","journal_article","type-journal_article","status-publish","hentry","topic-pharmacoepidemiology-and-drug-safety"],"acf":{"citation":"Clark JP, Dasgupta M, Rochon PA. <em>Mature Med Can<\/em>. 1998; 1(3):28-29.","source_url":"","ices_scientist":[1340],"site":[6735],"research_program":[6746],"news_release":[],"journal_article":[],"atlas":[],"research_report":[],"infographic":[],"video":[],"downloads":null,"links":null,"sitecore_item_id":"2C034885-93D1-49CF-BB95-5A246E1F72C2","sitecore_item_name":"A-research-program-to-evaluate-the-benefits-of-low-dose-cardiovascular-medications","sitecore_field_values":"{\n  \"Title\": \"A research program to evaluate the benefits of low dose cardiovascular medications: optimizing prescribing for older women\",\n  \"Short title\": \"Optimizing prescribing for older women\",\n  \"Citation\": \"<p>Clark JP, Dasgupta M, Rochon PA. <em>Mature Med Can<\/em>. 1998; 1(3):28-29.<\/p>\",\n  \"Abstract\": \"<p>Developing strategies to optimize prescribing for seniors is important because prescription drug expenditures for this group are increasing at a faster rate than any other Canadian healthcare cost. While seniors represent only 12% of the they receive up to 40% of all medications prescribed, amounting to an average of five medications daily. In addition, older people are vulnerable to adverse drug effects which can be dangerous and costly. Medication problems account for up to 28% of hospital admissions for patients over 50,4 up to 70% of which are due to adverse drug reaction. In the U.S., the annual cost of drug-related morbidity and mortality in the ambulatory setting is estimated at 76.6 billion dollars. Therefore, drug-related morbidity and mortality represents a serious though largely preventable medical problem.<\/p>\",\n  \"Keywords\": \"{D4620196-76F6-4AE4-9103-FB996B44FAC4}|{E86C786D-011F-4280-894D-32554E81838A}\",\n  \"Research Programs\": \"{CFE36C89-C969-4C23-B5E4-1BA9E5BDC273}\",\n  \"ICES Locations\": \"{FBE2D1B1-C0BA-423F-8D16-39466B6C1424}\",\n  \"ICES Scientists\": \"{14B76C34-3A35-4785-86C4-9B1633E28765}\",\n  \"Posted Date\": \"19980101T000000\"\n}","previous_url":"https:\/\/www.ices.on.ca\/Publications\/Journal-Articles\/1998\/January\/A-research-program-to-evaluate-the-benefits-of-low-dose-cardiovascular-medications"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ICES | A research program to evaluate the benefits of low dose cardiovascular medications: optimizing prescribing for older women<\/title>\n<meta name=\"description\" content=\"Developing strategies to optimize prescribing for seniors is important because prescription drug expenditures for this group are increasing at a faster\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/a-research-program-to-evaluate-the-benefits-of-low-dose-cardiovascular-medications-optimizing-prescribing-for-older-women\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ICES | A research program to evaluate the benefits of low dose cardiovascular medications: optimizing prescribing for older women\" \/>\n<meta property=\"og:description\" content=\"Developing strategies to optimize prescribing for seniors is important because prescription drug expenditures for this group are increasing at a faster\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/a-research-program-to-evaluate-the-benefits-of-low-dose-cardiovascular-medications-optimizing-prescribing-for-older-women\/\" \/>\n<meta property=\"og:site_name\" content=\"ICES\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ICESOntario\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-14T23:37:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/a-research-program-to-evaluate-the-benefits-of-low-dose-cardiovascular-medications-optimizing-prescribing-for-older-women\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/a-research-program-to-evaluate-the-benefits-of-low-dose-cardiovascular-medications-optimizing-prescribing-for-older-women\\\/\",\"name\":\"ICES | A research program to evaluate the benefits of low dose cardiovascular medications: optimizing prescribing for older women\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\"},\"datePublished\":\"1998-01-01T05:00:00+00:00\",\"dateModified\":\"2023-06-14T23:37:56+00:00\",\"description\":\"Developing strategies to optimize prescribing for seniors is important because prescription drug expenditures for this group are increasing at a faster\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/a-research-program-to-evaluate-the-benefits-of-low-dose-cardiovascular-medications-optimizing-prescribing-for-older-women\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/a-research-program-to-evaluate-the-benefits-of-low-dose-cardiovascular-medications-optimizing-prescribing-for-older-women\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/a-research-program-to-evaluate-the-benefits-of-low-dose-cardiovascular-medications-optimizing-prescribing-for-older-women\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Journal Articles\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"A research program to evaluate the benefits of low dose cardiovascular medications: optimizing prescribing for older women\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"name\":\"ICES\",\"description\":\"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\"},\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\",\"name\":\"ICES\",\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"width\":\"676\",\"height\":\"618\",\"caption\":\"ICES\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ICESOntario\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ices-research-institute\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ICES | A research program to evaluate the benefits of low dose cardiovascular medications: optimizing prescribing for older women","description":"Developing strategies to optimize prescribing for seniors is important because prescription drug expenditures for this group are increasing at a faster","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/a-research-program-to-evaluate-the-benefits-of-low-dose-cardiovascular-medications-optimizing-prescribing-for-older-women\/","og_locale":"fr_FR","og_type":"article","og_title":"ICES | A research program to evaluate the benefits of low dose cardiovascular medications: optimizing prescribing for older women","og_description":"Developing strategies to optimize prescribing for seniors is important because prescription drug expenditures for this group are increasing at a faster","og_url":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/a-research-program-to-evaluate-the-benefits-of-low-dose-cardiovascular-medications-optimizing-prescribing-for-older-women\/","og_site_name":"ICES","article_publisher":"https:\/\/www.facebook.com\/ICESOntario\/","article_modified_time":"2023-06-14T23:37:56+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/a-research-program-to-evaluate-the-benefits-of-low-dose-cardiovascular-medications-optimizing-prescribing-for-older-women\/","url":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/a-research-program-to-evaluate-the-benefits-of-low-dose-cardiovascular-medications-optimizing-prescribing-for-older-women\/","name":"ICES | A research program to evaluate the benefits of low dose cardiovascular medications: optimizing prescribing for older women","isPartOf":{"@id":"https:\/\/www.ices.on.ca\/fr\/#website"},"datePublished":"1998-01-01T05:00:00+00:00","dateModified":"2023-06-14T23:37:56+00:00","description":"Developing strategies to optimize prescribing for seniors is important because prescription drug expenditures for this group are increasing at a faster","breadcrumb":{"@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/a-research-program-to-evaluate-the-benefits-of-low-dose-cardiovascular-medications-optimizing-prescribing-for-older-women\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/a-research-program-to-evaluate-the-benefits-of-low-dose-cardiovascular-medications-optimizing-prescribing-for-older-women\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/a-research-program-to-evaluate-the-benefits-of-low-dose-cardiovascular-medications-optimizing-prescribing-for-older-women\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ices.on.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Journal Articles","item":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/"},{"@type":"ListItem","position":3,"name":"A research program to evaluate the benefits of low dose cardiovascular medications: optimizing prescribing for older women"}]},{"@type":"WebSite","@id":"https:\/\/www.ices.on.ca\/fr\/#website","url":"https:\/\/www.ices.on.ca\/fr\/","name":"ICES","description":"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE","publisher":{"@id":"https:\/\/www.ices.on.ca\/fr\/#organization"},"alternateName":"Institute for Clinical Evaluative Sciences","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ices.on.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ices.on.ca\/fr\/#organization","name":"ICES","alternateName":"Institute for Clinical Evaluative Sciences","url":"https:\/\/www.ices.on.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","contentUrl":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","width":"676","height":"618","caption":"ICES"},"image":{"@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ICESOntario\/","https:\/\/www.linkedin.com\/company\/ices-research-institute\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/journal_article\/3413","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/journal_article"}],"about":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/types\/journal_article"}],"acf:post":[{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/research_program\/6746"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/site\/6735"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/ices_scientist\/1340"}],"wp:attachment":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/media?parent=3413"}],"wp:term":[{"taxonomy":"migration-helper-automated","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-helper-automated?post=3413"},{"taxonomy":"migration-manual","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-manual?post=3413"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/topic?post=3413"},{"taxonomy":"migration-helper-qa-sample-set","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-helper-qa-sample-set?post=3413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}